Linked Life Data

10796546

Source:http://linkedlifedata.com/resource/pubmed/id/10796546

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2000-7-6
pubmed:abstractText
Since the 1950s neuroleptic medication has been extensively used to treat people with chronic mental illnesses, such as schizophrenia. These drugs, however, have been also associated with a wide range of adverse effects, including movement disorders such as tardive dyskinesia (TD). Various strategies have been examined to reduce a person's cumulative exposure to neuroleptics. These studies include dose reduction, intermittent dosing strategies, such as drug holidays, and neuroleptic cessation.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1469-493X
pubmed:author
pubmed:issnType
Electronic
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
CD000459
pubmed:dateRevised
2006-4-7
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
pubmed:affiliation
Queensland Centre for Schizophrenia Research, Wolston Park Hospital, Brisbane, Queensland, Australia, Q4076. jjm@brain.wph.uq.oz.au
pubmed:publicationType
Journal Article, Review